These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 32430222)

  • 1. Public Health Clinic-Based Hepatitis C Treatment.
    Rosecrans AM; Cheedalla A; Rives ST; Scotti LA; Harris RE; Greenbaum AH; Irvin RR; Ntiri-Reid BA; Brown HT; Alston KE; Smith JA; Page KR; Falade-Nwulia OO
    Am J Prev Med; 2020 Sep; 59(3):420-427. PubMed ID: 32430222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
    Kieran J; Dillon A; Farrell G; Jackson A; Norris S; Mulcahy F; Bergin C
    Int J STD AIDS; 2011 Oct; 22(10):571-6. PubMed ID: 21998177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in hepatitis C treatment initiation among HIV/hepatitis C virus-coinfected men engaged in primary care in a multisite community health centre in Maryland: a retrospective cohort study.
    Chen YC; Thio CL; Cox AL; Ruhs S; Kamangar F; Wiberg KJ
    BMJ Open; 2019 Mar; 9(3):e027411. PubMed ID: 30928964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A financial incentive program to improve appointment attendance at a safety-net hospital-based primary care hepatitis C treatment program.
    Lee KS; Quintiliani L; Heinz A; Johnson NL; Xuan Z; Truong V; Lasser KE
    PLoS One; 2020; 15(2):e0228767. PubMed ID: 32045447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic.
    Mehta SH; Lucas GM; Mirel LB; Torbenson M; Higgins Y; Moore RD; Thomas DL; Sulkowski MS
    AIDS; 2006 Nov; 20(18):2361-9. PubMed ID: 17117023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public health clinic-based hepatitis C testing and linkage to care in Baltimore.
    Falade-Nwulia O; Mehta SH; Lasola J; Latkin C; Niculescu A; O'Connor C; Chaulk P; Ghanem K; Page KR; Sulkowski MS; Thomas DL
    J Viral Hepat; 2016 May; 23(5):366-74. PubMed ID: 26840570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic.
    Assoumou SA; Wang J; Nolen S; Eftekhari Yazdi G; Mayer KH; Puro J; Salomon JA; Linas BP
    J Gen Intern Med; 2020 May; 35(5):1477-1483. PubMed ID: 32133577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV).
    Fadnes LT; Aas CF; Vold JH; Ohldieck C; Leiva RA; Chalabianloo F; Skurtveit S; Lygren OJ; Dalgård O; Vickerman P; Midgard H; Løberg EM; Johansson KA;
    BMC Infect Dis; 2019 Nov; 19(1):943. PubMed ID: 31703669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Earlier Detection of Hepatitis C Virus Infection Through Routine Hepatitis C Virus Antibody Screening of Human Immunodeficiency Virus-Positive Men Who Have Sex With Men Attending A Sexually Transmitted Infection Outpatient Clinic: A Longitudinal Study.
    van Rooijen M; Heijman T; de Vrieze N; Urbanus A; Speksnijder A; van Leeuwen P; de Vries H; Prins M
    Sex Transm Dis; 2016 Sep; 43(9):560-5. PubMed ID: 27513382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
    Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for hepatitis C infection among adult patients in Kedah state, Malaysia: A case-control study.
    Mohd Suan MA; Said SM; Lim PY; Azman AZF; Abu Hassan MR
    PLoS One; 2019; 14(10):e0224459. PubMed ID: 31661525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cascade of Hepatitis C Virus Care Among Patients With Substance Use Disorders.
    Jiang X; Parker RL; Vouri SM; Lo-Ciganic W; Diaby V; Henry L; Park H
    Am J Prev Med; 2021 Oct; 61(4):576-584. PubMed ID: 34210584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan.
    McDonald SA; Hutchinson SJ; Innes HA; Allen S; Bramley P; Bhattacharyya D; Carman W; Dillon JF; Fox R; Fraser A; Goldberg DJ; Kennedy N; Mills PR; Morris J; Stanley AJ; Wilks D; Hayes PC
    J Viral Hepat; 2014 May; 21(5):366-76. PubMed ID: 24716639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional epidemiology of hepatitis C virus detection and treatment in HIV-infected patients.
    Ena J; Ruiz-de-Apodaca RF; Pasquau F; Amador C; Benito C
    Eur J Intern Med; 2011 Feb; 22(1):66-72. PubMed ID: 21238897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience of a Portuguese Center: Effectiveness of Direct-Acting Antiviral Therapy for Hepatitis C.
    Falcão F; Lopes C; Viegas E; Perez R; Aldir I; Farinha H; Carvalho A; Mirco A; Marques S; Bana E Costa T; Miranda AC; Lebre L; Peixe P; Chagas C; Mansinho K; Correia JM
    Acta Med Port; 2019 Mar; 32(3):189-194. PubMed ID: 30946789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study.
    Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ;
    J Viral Hepat; 2020 Mar; 27(3):281-293. PubMed ID: 31698545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a Nurse Care Coordinator Supporting a Clinical Pharmacist Practitioner in Further Managing HCV-Infected Patients.
    Yang A; Zachary D; Giang J
    Gastroenterol Nurs; 2021 Jan-Feb 01; 44(1):E11-E17. PubMed ID: 33464766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service.
    Wade AJ; Macdonald DM; Doyle JS; Gordon A; Roberts SK; Thompson AJ; Hellard ME
    PLoS One; 2015; 10(11):e0142770. PubMed ID: 26562516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.
    Lam JO; Hurley LB; Chamberland S; Champsi JH; Gittleman LC; Korn DG; Lai JB; Quesenberry CP; Ready J; Saxena V; Seo SI; Witt DJ; Silverberg MJ; Marcus JL
    Int J STD AIDS; 2019 Jun; 30(7):689-695. PubMed ID: 31046611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Successes in an Open Access, Provincially Funded Hepatitis C Treatment Program in Prince Edward Island.
    Francheville JW; Rankin R; Beck J; Hoare C; Materniak S; German G; Barrett L; Bunimov-Wall N; Smyth D
    Ann Hepatol; 2018; 17(2):223-231. PubMed ID: 31097237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.